A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

A looming industry-wide shift in digital certificate validation could leave up to 40% of enterprises vulnerable to website outages and service interruptions, according to new research released ...